| Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection G Sinkovits, B Mező, M Réti, V Müller, Z Iványi, J Gál, L Gopcsa, ... Frontiers in immunology 12, 663187, 2021 | 102 | 2021 |
| Associations between the von Willebrand factor—ADAMTS13 axis, complement activation, and COVID-19 severity and mortality G Sinkovits, M Réti, V Müller, Z Ivanyi, J Gal, L Gopcsa, P Remenyi, ... Thrombosis and Haemostasis 122 (02), 240-256, 2022 | 20 | 2022 |
| Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups L Hurler, Á Szilágyi, F Mescia, L Bergamaschi, B Mező, G Sinkovits, ... Frontiers in immunology 14, 1162171, 2023 | 12 | 2023 |
| Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs L Hurler, EJM Toonen, E Kajdácsi, B van Bree, RJ Brandwijk, W de Bruin, ... Frontiers in immunology 13, 1039765, 2022 | 12 | 2022 |
| Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children G Sinkovits, J Schnur, L Hurler, P Kiszel, ZZ Prohászka, P Sík, E Kajdácsi, ... Scientific Reports 12 (1), 19759, 2022 | 9 | 2022 |
| Complement levels at admission reflecting progression to severe acute kidney injury (AKI) in Coronavirus disease 2019 (COVID-19): A multicenter prospective cohort study BM Henry, G Sinkovits, I Szergyuk, MHS de Oliveira, G Lippi, JL Benoit, ... Frontiers in medicine 9, 796109, 2022 | 6 | 2022 |
| Differentiating between activation via the lectin or the classical complement pathway in patients with systemic lupus erythematosus ML Larsen, A Troldborg, EJM Toonen, L Hurler, Z Prohaszka, L Cervenak, ... Clinical and Experimental Immunology 214 (1), 18-25, 2023 | 1 | 2023 |
| Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes E Kodosaki, WJ Watkins, S Loveless, KL Kreft, A Richards, V Anderson, ... Journal of Neuroinflammation 21 (1), 1-15, 2024 | | 2024 |
| Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection M Avraham, G Sinkovits, L Hurler, Z Prohászka, Z Fishelson Frontiers in Immunology 15, 1337215, 2024 | | 2024 |
| Storage of Transfusion Platelet Concentrates Is Associated with Complement Activation and Reduced Ability of Platelets to Respond to Protease-Activated Receptor-1 and … LI Andersson, DJ Sjöström, HQ Quach, K Hägerström, L Hurler, ... International Journal of Molecular Sciences 25 (2), 1091, 2024 | | 2024 |
| 96 Association between acute stage biomarker levels, severity and long-term outcome in COVID-19 L Hurler, F Mescia, L Bergamaschi, E Kajdácsi, G Sinkovits, L Cervenak, ... Immunobiology 228 (5), 152547, 2023 | | 2023 |
| DEVELOPMENT OF IMMUNOASSAYS FOR SPECIFIC CLASSICAL AND LECTIN PATHWAY ACTIVATION MARKERS L Hurler | | 2023 |
| Measurements of Specific Activation Through the Lectin-or Classical Pathway of Complement in Patients with SLE A Troldborg, ML Larsen, EJM Toonen, L Hurler, Z Prohaszka, L Cervenak, ... ARTHRITIS & RHEUMATOLOGY 74, 3374-3376, 2022 | | 2022 |
| POS0060 MEASUREMENTS OF COMPLEMENT ACTIVITY SPECIFICALLY THOUGH THE LECTIN-OR THE CLASSICAL PATHWAY IN PATIENTS WITH SLE MCL Larsen, A Troldborg, E Toonen, L Hurler, Z Prohászka, L Cervenak, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 246-246, 2022 | | 2022 |
| Development of immunoassays for specific classical and lectin pathway activation markers and investigation of complement activation in COVID-19 L Hurler, EJM Toonen, E Kajdacsi, B van Bree, G Sinkovits, L Cervenak, ... MOLECULAR IMMUNOLOGY 141, 166-167, 2022 | | 2022 |
| Prothrombotic alterations of von Willebrand factor level and ADAMTS13 activity in hospitalized COVID-19 patients G Sinkovits, B Mező, M Réti, V Müller, Z Iványi, J Gál, L Gopcsa, ... Hämostaseologie 41 (S 01), OC10-02, 2021 | | 2021 |
